Laura Oliphant Sells 1,716 Shares of Aehr Test Systems (NASDAQ:AEHR) Stock

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) Director Laura Oliphant sold 1,716 shares of Aehr Test Systems stock in a transaction dated Thursday, April 16th. The stock was sold at an average price of $81.54, for a total value of $139,922.64. Following the sale, the director directly owned 16,716 shares in the company, valued at approximately $1,363,022.64. This trade represents a 9.31% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

• Up Over 200% in 2026, What's Next for AI Stock Aehr Test Systems?

Laura Oliphant also recently made the following trade(s):

• On Thursday, April 16th, Laura Oliphant sold 4,665 shares of Aehr Test Systems stock. The shares were sold at an average price of $85.59, for a total transaction of $399,277.35.
• On Thursday, April 9th, Laura Oliphant sold 3,000 shares of Aehr Test Systems stock. The stock was sold at an average price of $68.36, for a total transaction of $205,080.00.
• On Thursday, January 22nd, Laura Oliphant sold 4,546 shares of Aehr Test Systems stock. The shares were sold at an average price of $31.40, for a total transaction of $142,744.40.

Aehr Test Systems Stock Up 3.7%

---

---

NASDAQ:AEHR opened at $83.86 on Friday. Aehr Test Systems has a 12-month low of $7.71 and a 12-month high of $91.43. The firm has a market capitalization of $2.64 billion, a PE ratio of -220.68 and a beta of 2.28. The firm has a 50-day moving average price of $42.81 and a 200 day moving average price of $31.03.

• AEHR Keeps Winning: Up +100% With Memory Chip Deal Potential

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last released its quarterly earnings data on Tuesday, April 7th. The semiconductor company reported ($0.05) earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.02. Aehr Test Systems had a negative return on equity of 7.15% and a negative net margin of 25.23%.The company had revenue of $10.31 million for the quarter, compared to the consensus estimate of $10.85 million. On average, research analysts expect that Aehr Test Systems will post 0.1 EPS for the current year.

Aehr Test Systems News Roundup

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Record $41M hyperscale AI production order — the follow‑on order is for package‑level burn‑in of custom AI ASICs and is described as the largest in company history, providing a clear near‑term revenue and capacity catalyst. Accesswire: Record $41M order
• Positive Sentiment: Bookings/backlog strength tied to AI/data‑center demand — company updates and coverage report second‑half bookings exceeding ~$92M and a record backlog, supporting upside to FY2027 revenue if orders convert. Benzinga: record deal & bookings
• Positive Sentiment: Analyst optimism and higher price targets — recent upgrades and bumped targets have reinforced investor interest and helped attract institutional/retail flows. MSN: price target increase
• Positive Sentiment: Technical/momentum factors may amplify moves — a recent golden‑cross and elevated short interest increase the likelihood of follow‑through and short covering when positive headlines arrive. Seeking Alpha: movers summary
• Neutral Sentiment: Volatility and coverage: several outlets note extreme YTD moves (one headline cites a 300% move) — useful as context for sentiment but not a direct fundamental change. InsiderMonkey: AEHR up 300%
• Neutral Sentiment: Mixed quarterly fundamentals — AEHR beat EPS slightly but missed revenue; execution to convert large bookings into sustained, profitable growth remains the key risk. MarketBeat: quarterly results
• Negative Sentiment: Clustered insider selling — multiple executives and directors disclosed sizable share sales (including director and C‑suite transactions in mid‑April), which can create near‑term selling pressure and raise investor questions about insider conviction. InsiderTrades: insider selling
• Negative Sentiment: Media and aggregation highlight insider liquidity events — coverage emphasizing millions in insider proceeds can weigh on sentiment even if some sales are routine or for tax purposes. TipRanks: insider sell-off

Institutional Investors Weigh In On Aehr Test Systems

• MarketBeat Week in Review – 02/16 - 02/20

A number of institutional investors and hedge funds have recently modified their holdings of the business. Royal Bank of Canada grew its holdings in Aehr Test Systems by 262.7% during the 1st quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company's stock worth $365,000 after acquiring an additional 36,364 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Aehr Test Systems by 8.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company's stock worth $126,000 after purchasing an additional 1,344 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Aehr Test Systems by 7.9% during the second quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company's stock worth $201,000 after purchasing an additional 1,145 shares during the period. Legal & General Group Plc increased its holdings in Aehr Test Systems by 110.8% in the second quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company's stock valued at $89,000 after purchasing an additional 3,617 shares during the last quarter. Finally, Rhumbline Advisers lifted its stake in Aehr Test Systems by 3.1% in the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company's stock valued at $536,000 after buying an additional 1,254 shares during the period. 69.69% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Wall Street Zen raised Aehr Test Systems from a "strong sell" rating to a "sell" rating in a report on Saturday, April 11th. Weiss Ratings restated a "sell (d)" rating on shares of Aehr Test Systems in a research report on Wednesday, January 21st. Craig Hallum raised shares of Aehr Test Systems from a "hold" rating to a "buy" rating and set a $68.00 price objective for the company in a report on Wednesday, April 8th. Lake Street Capital reissued a "buy" rating on shares of Aehr Test Systems in a report on Wednesday, April 8th. Finally, William Blair upgraded Aehr Test Systems from a "market perform" rating to an "outperform" rating in a research report on Monday, March 2nd. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $68.00.

Get Our Latest Stock Analysis on AEHR

About Aehr Test Systems

(Get Free Report)

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company's product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.

See Also

• Five stocks we like better than Aehr Test Systems

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].